Edition:
United Kingdom

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

3.74USD
17 Nov 2017
Change (% chg)

$0.08 (+2.19%)
Prev Close
$3.66
Open
$3.62
Day's High
$3.88
Day's Low
$3.62
Volume
710
Avg. Vol
4,098
52-wk High
$15.12
52-wk Low
$3.42

Select another date:

Wed, Nov 8 2017

BRIEF-Novus Therapeutics Inc reported Q3 $0.43 loss per share​

* Novus Therapeutics Inc - ‍for Q3 of 2017, Novus reported $0.43 loss per share​ Source text: (http://bit.ly/2hldAkp) Further company coverage:

BRIEF-Novus Therapeutics reports third quarter 2017 results

* Q3 loss per share $0.43 Source text for Eikon: Further company coverage:

BRIEF-Novus Therapeutics reports Q2 loss per share $1.32

* Q2 loss per share $1.32 Source text for Eikon: Further company coverage:

BRIEF-S.Africa's Competition Tribunal says Caxton cannot intervene in Media24-Novus merger

* Has rejected Caxton's application for leave to intervene in merger hearings concerning merger between Media24 and Novus

Select another date: